Dendreon Highlights The Best Of The Web

By Steven Bulwa:

The Internet has democratized the availability of information and Seeking Alpha is a microcosm of the best aspects of this change. Independent analysts without the prejudice of the financial entanglements of Wall Street bankers are now just as able to offer opinions and disseminate information as that long-standing establishment. For investors, this is a welcome change and an opportunity to identify more opportunities and make better-informed valuable independent investment decisions. Dendreon (DNDN) has long been a polarizing proposition for investors, a company with a potentially blockbuster drug that has as many adamant supporters as inexorable dissenters. A series of recent articles on Seeking Alpha have pushed me firmly into the bull camp.

Dendreon Polarizes Investors

Dendreon is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics for treating cancer. The company’s product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a wide

Complete Story »

Seeking Alpha Editors’ Picks stocks

Short URL:

Posted by on Apr 23 2012. Filed under Finance. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

mugen 2d fighting games

Photo Gallery

120x600 ad code [Inner pages]
Log in | Wp Advanced Newspaper WordPress Themes Designed by Gabfire themes Free WordPress Themes
Wp Advanced Newspaper WordPress Themes Gabfire